Jiangsu Recbio Technology and Biological E. Limited are partnering for HPV9 vaccine. Recbio will transfer technology to Biological E. Limited. This will allow Biological E. Limited to manufacture and commercialize the vaccine. The goal is to make the vaccine accessible in India and other markets. This collaboration aims to prevent cervical cancer.